MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Drops

国药准字H20244302

June 28, 2024

Drug Information

盐酸左西替利嗪口服滴剂

口服溶液剂

20ml:100mg

化学药品

June 28, 2024

Company Information

Applicant Company

山西省大同经济技术开发区思贤街90号全盛·沄兴研发大楼310室(一照多址)

Manufacturing Company

山西省大同市经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服滴剂 - NMPA 批准文号 | MedPath